Middle East and Africa RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Molecule Type (Small Interfering RNAs (siRNA) and MicroRNA (miRNA)), Application (Genetic Disorders, Oncology, Neurodegenerative Disorders, Cardiovascular, Respiratory Disorders, Infectious Diseases, Renal Diseases, and Others), Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, and Others), and End User (Diagnostic Laboratories, Research and Academic Laboratories, and Hospitals); and Country

Name: Middle East and Africa RNAi Therapeutics Market
SKU: Biotechnology
Rating: 4.9 (10 reviews)

Market Introduction

RNA interference (RNAi) is a vital biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. RNAi is an essential research tool in cell culture and living organisms because synthetic dsRNA introduced into cells can induce the suppression of specific genes of interest. RNAi may be used for large-scale screens that orderly shutdown each gene in the cell, which can help to know the components necessary for a particular cellular event such as cell division. The pathway is also used as a practical tool in medicine, biotechnology, and insecticides.

Get more information on this report :

Market Overview and Dynamics

The Middle East & Africa RNAi therapeutics market is expected to reach US$ 29.02 million by 2027 from US$ 16.76 million in 2019. The market is anticipated to grow at a CAGR of 7.2% during 2019–2027. The growth of the market is attributed to factors such as growing investments in RNAi therapies and rising prevalence of infectious diseases & chronic conditions. However, high cost of RNAi therapy development is expected to restrain the growth of the market to a certain extent during the forecast period.

Key Market Segments

In terms of molecule type, the small interfering RNAs (siRNA) segment accounted for larger share of the Middle East & Africa RNAi therapeutics market in 2019. Based on route of administration, the pulmonary delivery segment held the largest share of the Middle East & Africa RNAi therapeutics market in 2019. In terms of application, the oncology segment accounted for the largest share of the market in 2019. Based on end user, the research and academic laboratories segment held the largest share of the Middle East & Africa RNAi therapeutics market in 2019.

Major Sources and Companies Listed

Major primary and secondary sources associated with the Middle East & Africa RNAi therapeutics market report are the World Health Organization (WHO), International Agency of Research on Cancer and Prevention, Worldometer, and others.

Reasons to buy report

It provides understanding of the Middle East & Africa RNAi therapeutics market landscape and identifies RNAi therapeutics market segments that are most likely to guarantee a strong return
It guides to stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East & Africa RNAi therapeutics market
It helps efficiently plan merger and acquisition and partnership deals in the RNAi therapeutics market by identifying market segments with the most promising probable sales
It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of various segments pertaining to the Middle East & Africa RNAi therapeutics market.
It provides revenue forecast of the market based on various segments for the period from 2019 to 2027

MIDDLE EAST & AFRICA RNAI THERAPEUTICS MARKET SEGMENTATION

By Molecule Type

Small Interfering RNAs (siRNA)
MicroRNA (miRNA)

By Route of Administration

Pulmonary Delivery
Intravenous Injections
Intradermal Injections
Intraperitoneal Injections
Others

By Application

By End User

Research and Academic Laboratories
Hospitals
Diagnostic Laboratories

By Country

UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Company Profiles

Benitec Biopharma
Olix Pharmaceuticals, Inc.
GlaxoSmithKline plc
Alnylam Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa RNAi Therapeutics Market – By Molecule Type

1.3.2 Middle East & Africa RNAi Therapeutics Market – By Application

1.3.3 Middle East & Africa RNAi Therapeutics Market – By Route of Administration

1.3.4 Middle East & Africa RNAi Therapeutics Market– By End User

1.3.5 Middle East & Africa RNAi Therapeutics Market – By Country

2. Middle East & Africa RNAi Therapeutics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa RNAi Therapeutics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 RNAi therapeutics Market - Middle East & Africa PEST Analysis

4.3 Expert Opinion

5. Middle East & Africa RNAi Therapeutics Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Growing Investments in RNAi Therapies

5.1.2 Rising Prevalence of Chronic Conditions and Infectious Diseases

5.2 Market Restraints

5.2.1 High Cost for RNAi Therapy Development

5.3 Market Opportunities

5.3.1 Significant Number of Pipeline Candidates for Strategic Alliances

5.4 Future Trends

5.4.1 Rising Emphasis on RNA Technologies

5.5 Impact analysis

6. RNAi Therapeutics Market – Middle East & Africa Analysis

6.1 Middle East & Africa RNAi Therapeutics Market Revenue Forecasts and Analysis

7. Middle East & Africa RNAi Therapeutics Market Analysis and Forecasts To 2027 – By Molecule Type

7.1 Overview

7.2 Middle East & Africa RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)

7.2.1 Middle East & Africa RNAi therapeutics Market Revenue and Forecasts to 2027, By Molecule Type (US$ Mn)

7.3 Small Interfering RNAs (siRNA)

7.3.1 Overview

7.3.2 Middle East & Africa Small Interfering RNAs (siRNA) Market Revenue and Forecast to 2027 (US$ Mn)

7.4 MicroRNA (miRNA)

7.4.1 Overview

7.4.2 Middle East & Africa MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

8. Middle East & Africa RNAi therapeutics Market Analysis and Forecasts To 2027 – By Application

8.1 Overview

8.2 Middle East & Africa RNAi therapeutics Market, By Application 2019 & 2027 (%)

8.2.1 Middle East & Africa RNAi therapeutics Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3 Genetic Disorders

8.3.1 Overview

8.3.2 Middle East & Africa Genetic Disorders Market Revenue and Forecast to 2027 (US$ Mn)

8.4 Oncology

8.4.1 Overview

8.4.2 Middle East & Africa Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Neurodegenerative Disorders

8.5.1 Overview

8.5.2 Middle East & Africa Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.6 Cardiovascular Disorders

8.6.1 Overview

8.6.2 Middle East & Africa Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.7 Respiratory Disorders

8.7.1 Overview

8.7.2 Middle East & Africa Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.8 Infectious Diseases

8.8.1 Overview

8.8.2 Middle East & Africa Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

8.9 Renal Diseases

8.9.1 Overview

8.9.2 Middle East & Africa Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

8.10 Other Disorders

8.10.1 Overview

8.10.2 Middle East & Africa Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

9. Middle East & Africa RNAi therapeutics Market Analysis and Forecasts To 2027 – By Route of Administration

9.1 Overview

9.2 Middle East & Africa RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)

9.2.1 Middle East & Africa RNAi therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

9.3 Intradermal Injections

9.3.1 Overview

9.3.2 Middle East & Africa Intradermal Injections Market Revenue and Forecast to 2027 (US$ Mn)

9.4 Pulmonary Delivery

9.4.1 Overview

9.4.2 Middle East & Africa Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Intravenous Injections

9.5.1 Overview

9.5.2 Middle East & Africa Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)

9.6 Intraperitoneal Injections

9.6.1 Overview

9.6.2 Middle East & Africa Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

9.7 Other Route of Administrations

9.7.1 Overview

9.7.2 Middle East & Africa Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

10. Middle East & Africa RNAi Therapeutics Market Analysis – By End-User

10.1 Overview

10.2 Middle East & Africa RNAi Therapeutics Market, By End-User 2019-2027 (%)

10.2.1 Middle East & Africa RNAi Therapeutics Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

10.3 Diagnostic Laboratories

10.3.1 Overview

10.3.2 Middle East & Africa Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

10.4 Research and Academic Laboratories

10.4.1 Overview

10.4.2 Middle East & Africa Research and Academic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

10.5 Hospitals

10.5.1 Overview

10.5.2 Middle East & Africa Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

11. RNAi therapeutics Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1 Middle East & Africa: RNAi Therapeutics Market

11.1.1 Overview

11.1.2 Middle East & Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)

11.1.3 Middle East & Africa: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.4 Middle East & Africa RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.5 Middle East & Africa: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.6 Middle East & Africa RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.7 Middle East & Africa: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)

11.1.8 Saudi Arabia: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1 Saudi Arabia: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2 Saudi Arabia: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.8.3 Saudi Arabia RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.8.4 Saudi Arabia: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.8.5 Saudi Arabia RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.9 UAE: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1 UAE: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2 UAE: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.9.3 UAE RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.9.4 UAE: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.9.5 UAE RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.10 South Africa: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 South Africa: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 South Africa: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.10.3 South Africa RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.10.4 South Africa RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.10.5 South Africa RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

12. Impact of COVID-19 Pandemic on Middle East & Africa RNAi therapeutics Market

12.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

13. Company Profiles

13.1 Benitec Biopharma

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Olix Pharmaceuticals, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GlaxoSmithKline plc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Alnylam Pharmaceuticals, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Arrowhead Pharmaceuticals, Inc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa RNAi therapeutics Market Revenue and Forecasts To 2027, By Molecule Type (US$ Mn)

Table 2. Middle East & Africa RNAi therapeutics Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3. Middle East & Africa RNAi therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

Table 4. Middle East & Africa RNAi Therapeutics Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 5. Middle East & Africa RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 6. Middle East & Africa RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7. Middle East & Africa RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 8. Middle East & Africa RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 9. Saudi Arabia RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 10. Saudi Arabia RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11. Saudi Arabia RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 12. Saudi Arabia RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13. UAE RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 14. UAE RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15. UAE RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 16. UAE RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17. South Africa RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 18. South Africa RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 19. South Africa RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 20. South Africa RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21. Glossary of Terms, RNAi Therapeutics Market

LIST OF FIGURES

Figure 1. RNAi Therapeutics Market Segmentation

Figure 2. Middle East & Africa RNAi Therapeutics Market Overview

Figure 3. Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market

Figure 4. UAE is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Middle East & Africa RNAi Therapeutics Market - Leading Country Markets (US$ Mn)

Figure 6. RNAi Therapeutics Market - Middle East & Africa PEST Analysis

Figure 7. RNAi Therapeutics Market Impact Analysis of Driver and Restraints

Figure 8. Middle East & Africa RNAi Therapeutics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. Middle East & Africa RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)

Figure 10. Middle East & Africa Small Interfering RNAs (siRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. Middle East & Africa MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. Middle East & Africa RNAi therapeutics Market, By Application 2019 & 2027 (%)

Figure 13. Middle East & Africa Genetic Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. Middle East & Africa Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15. Middle East & Africa Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16. Middle East & Africa Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17. Middle East & Africa Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18. Middle East & Africa Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. Middle East & Africa Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Middle East & Africa Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. Middle East & Africa RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)

Figure 22. Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23. Middle East & Africa Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. Middle East & Africa Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. Middle East & Africa Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. Middle East & Africa Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27. Middle East & Africa RNAi Therapeutics Market, by End-User 2019 & 2027 (%)

Figure 28. Middle East & Africa Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29. Middle East & Africa Research and Academic Laboratories Mark et Revenue and Forecasts to 2027 (US$ Mn)

Figure 30. Middle East & Africa Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31. Middle East & Africa: RNAi Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 32. Middle East & Africa RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)

Figure 33. Middle East & Africa: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)

Figure 34. Saudi Arabia: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35. UAE: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 36. South Africa: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 37. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets

The List of Companies - Middle East and Africa RNAi Therapeutics Market

Benitec Biopharma
GlaxoSmithKline plc
Olix Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa RNAi Therapeutics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa RNAi Therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample